Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles

J Virol. 2008 Feb;82(3):1185-94. doi: 10.1128/JVI.01219-07. Epub 2007 Nov 21.

Abstract

Hepatitis E virus is a nonenveloped RNA virus. However, the single capsid protein resembles a typical glycoprotein in that it contains a signal sequence and potential glycosylation sites that are utilized when recombinant capsid protein is overexpressed in cell culture. In order to determine whether these unexpected observations were biologically relevant or were artifacts of overexpression, we analyzed capsid protein produced during a normal viral replication cycle. In vitro transcripts from an infectious cDNA clone mutated to eliminate potential glycosylation sites were transfected into cultured Huh-7 cells and into the livers of rhesus macaques. The mutations did not detectably affect genome replication or capsid protein synthesis in cell culture. However, none of the mutants infected rhesus macaques. Velocity sedimentation analyses of transfected cell lysates revealed that mutation of the first two glycosylation sites prevented virion assembly, whereas mutation of the third site permitted particle formation and RNA encapsidation, but the particles were not infectious. However, conservative mutations that did not destroy glycosylation motifs also prevented infection. Overall, the data suggested that the mutations were lethal because they perturbed protein structure rather than because they eliminated glycosylation.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Capsid Proteins / genetics
  • Capsid Proteins / metabolism*
  • Cell Line
  • Glycosylation
  • Hepatitis E virus / genetics
  • Hepatitis E virus / physiology*
  • Humans
  • Macaca mulatta
  • Mutant Proteins / genetics
  • Mutant Proteins / metabolism
  • Virus Assembly / genetics
  • Virus Assembly / physiology*

Substances

  • Capsid Proteins
  • Mutant Proteins